Methadone formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/18 (2006.01) A61K 31/485 (2006.01) A61K 47/02 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01)

Patent

CA 2690824

The present application relates to formulations having a decreased abuse potential. In a representative embodiment, the formulation comprises methadone hydrochloride (6-(Dimethylamino)-4,4-diphenylheptan-3-one, a synthetic opioid), meglumine, cellulose, lactose and magnesium stearate. The application further illustrates methods for making the formulations. The use of formulations comprising a pharmaceutically acceptable salt of a narcotic drug having one positively charged protonated amine together with an alkalizing agent, for reducing potential for narcotic abuse is described.

La présente invention concerne de nouvelles préparations narcotiques présentant un potentiel réduit d'abus par injection. Dans un mode de réalisation représentatif, la formulation comprend du chlorhydrate de méthadone (6-diméthylamino-4,4-diphénylheptan-3-one, un opioïde synthétique), de la méglumine, de la cellulose, du lactose et du stéarate de magnésium. L'invention porte aussi sur des procédés de fabrication des préparations susmentionnées.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methadone formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methadone formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methadone formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1555000

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.